IMPROVED MEDICINAL FORM OF INTERFERON INDUCTOR

biochemistry, pharmacy. SUBSTANCE: invention relates to the improved medicinal form, suppositorium. Suppositorium has a double-strand complex of polyribouridylic and polyriboadenylic acids as interferon inductor, 200-250 mcg; hyaluronic acid, 10-20 mg; mixture of vitamins C and E as antioxidants, 30...

Full description

Saved in:
Bibliographic Details
Main Authors FADEEVA L.L, KASPAROV A.A, SAMOJLENKO I.I, SEMENOVA T.B
Format Patent
LanguageEnglish
Published 10.02.2001
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online AccessGet full text

Cover

More Information
Summary:biochemistry, pharmacy. SUBSTANCE: invention relates to the improved medicinal form, suppositorium. Suppositorium has a double-strand complex of polyribouridylic and polyriboadenylic acids as interferon inductor, 200-250 mcg; hyaluronic acid, 10-20 mg; mixture of vitamins C and E as antioxidants, 30-40 mg and base up to 1.5 g. Mass ratio of vitamins C and E in the mixture of antioxidants is 1:1 preferably. Novel medicinal form is used in treatment of patients with viral diseases of different etiology and provides the dosed release of an active component. EFFECT: improved quality, enhanced effectiveness, absence of adverse effects. 2 cl, 5 ex
Bibliography:Application Number: RU19980101738